Validation of the Post Sleep Questionnaire for Assessing Subjects with Restless Legs Syndrome: Results from Two Double-blind, Multicenter, Placebo-controlled Clinical Trials

Overview

Journal BMC Neurol

Publisher Biomed Central

Specialty Neurology

Date 2011 Apr 30

PMID 21527006

Citations 7

Authors

Daniel M Canafax

Abhijeet Bhanegaonkar

Murtuza Bharmal

Michael Calloway

Affiliations

Soon will be listed here.

Abstract

Background: Because of the subjective nature of Restless Legs Syndrome (RLS) symptoms and the impact of these symptoms on sleep, patient-reported outcomes (PROs) play a prominent role as study endpoints in clinical trials investigating RLS treatments. The objective of this study was to validate a new measure, the Post Sleep Questionnaire (PSQ), to assess sleep dysfunction in subjects with moderate-to-severe RLS symptoms.

Methods: Pooled data were analyzed from two 12-week, randomized, placebo-controlled trials of gabapentin enacarbil (N = 540). At baseline and Week 12, subjects completed the PSQ and other validated health surveys: IRLS Rating Scale, Clinical Global Impression of Improvement (CGI-I), Profile of Mood States (POMS), Medical Outcomes Study Scale-Sleep (MOS-Sleep), and RLS-Quality of Life (RLSQoL). Pooled data were used post hoc to examine the convergent, divergent, known-group validity and the responsiveness of the PSQ.

Results: Convergent validity was demonstrated by significant correlations between baseline PSQ items and total scores of IRLS, POMS, RLSQoL, and the MOS-Sleep Scale (p ≤ 0.007 each). Divergent validity was demonstrated through the lack of significant correlations between PSQ items and demographic characteristics. Correlations (p < 0.0001) between RLS severity groups and PSQ items demonstrated known-group validity. Mean changes in investigator- and subject-rated CGI-I scores for each PSQ item (p < 0.0001) demonstrated the PSQ's responsiveness to patient change as reported by their care provider.

Conclusions: Although these analyses were potentially limited by the use of clinical trial data and not prospective data from a study conducted solely for validation purposes, the PSQ demonstrated robust psychometric properties and is a valid instrument for assessing sleep and sleep improvements in subjects with moderate-to-severe RLS symptoms.

Trial Registration: This study analyzed data from two registered trials, NCT00298623 and NCT00365352.

Citing Articles

Restless legs syndrome is associated with long-COVID in women.

Weinstock L, Brook J, Walters A, Goris A, Afrin L, Molderings G J Clin Sleep Med. 2022; 18(5):1413-1418.

PMID: 35484639 PMC: 9059584. DOI: 10.5664/jcsm.9898.

A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder.

Mattingly G, Arnold V, Yan B, Yu M, Robertson B J Child Adolesc Psychopharmacol. 2020; 30(9):549-557.

PMID: 33185468 PMC: 7698843. DOI: 10.1089/cap.2020.0005.

Tools for the Assessment of Pediatric Restless Legs Syndrome.

Stubbs P, Walters A Front Psychiatry. 2020; 11:356.

PMID: 32431628 PMC: 7214695. DOI: 10.3389/fpsyt.2020.00356.

A Review of Scales to Evaluate Sleep Disturbances in Movement Disorders.

Kurtis M, Balestrino R, Rodriguez-Blazquez C, Forjaz M, Martinez-Martin P Front Neurol. 2018; 9:369.

PMID: 29896152 PMC: 5986889. DOI: 10.3389/fneur.2018.00369.

Gabapentin for the treatment of alcohol use disorder.

Mason B, Quello S, Shadan F Expert Opin Investig Drugs. 2017; 27(1):113-124.

PMID: 29241365 PMC: 5957503. DOI: 10.1080/13543784.2018.1417383.

References

Abetz L, Arbuckle R, Allen R, Mavraki E, Kirsch J . The reliability, validity and responsiveness of the Restless Legs Syndrome Quality of Life questionnaire (RLSQoL) in a trial population. Health Qual Life Outcomes. 2005; 3:79. PMC: 1322229. DOI: 10.1186/1477-7525-3-79. View

Abetz L, Vallow S, Kirsch J, Allen R, Washburn T, Earley C . Validation of the Restless Legs Syndrome Quality of Life questionnaire. Value Health. 2005; 8(2):157-67. DOI: 10.1111/j.1524-4733.2005.03010.x. View

Allen R, Picchietti D, Hening W, Trenkwalder C, Walters A, Montplaisi J . Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003; 4(2):101-19. DOI: 10.1016/s1389-9457(03)00010-8. View

Guyatt G, Walter S, Norman G . Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis. 1987; 40(2):171-8. DOI: 10.1016/0021-9681(87)90069-5. View

Guyatt G, Bombardier C, Tugwell P . Measuring disease-specific quality of life in clinical trials. CMAJ. 1986; 134(8):889-95. PMC: 1490966. View

Lee D, Ziman R, Perkins A, Poceta J, Walters A, Barrett R . A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome. J Clin Sleep Med. 2011; 7(3):282-92. PMC: 3113968. DOI: 10.5664/JCSM.1074. View

Kushida C, Becker P, Ellenbogen A, Canafax D, Barrett R . Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS. Neurology. 2009; 72(5):439-46. DOI: 10.1212/01.wnl.0000341770.91926.cc. View

Walters A, LeBrocq C, Dhar A, Hening W, Rosen R, Allen R . Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003; 4(2):121-32. DOI: 10.1016/s1389-9457(02)00258-7. View

Hays R, Martin S, Sesti A, Spritzer K . Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med. 2005; 6(1):41-4. DOI: 10.1016/j.sleep.2004.07.006. View

10.

Ulfberg J, Nystrom B, Carter N, Edling C . Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord. 2001; 16(6):1159-63. DOI: 10.1002/mds.1209. View

11.

Allen R, Kosinski M, Hill-Zabala C, Calloway M . Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep). Sleep Med. 2008; 10(5):531-9. DOI: 10.1016/j.sleep.2008.06.003. View

12.

Thomas K, Watson C . Restless legs syndrome in women: a review. J Womens Health (Larchmt). 2008; 17(5):859-68. DOI: 10.1089/jwh.2007.0515. View

13.

Hening W, Allen R . Restless legs syndrome (RLS): the continuing development of diagnostic standards and severity measures. Sleep Med. 2003; 4(2):95-7. DOI: 10.1016/s1389-9457(03)00009-1. View

14.

Hening W, Walters A, Allen R, Montplaisir J, Myers A, Ferini-Strambi L . Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004; 5(3):237-46. DOI: 10.1016/j.sleep.2004.03.006. View

15.

Hening W, Allen R, Washburn M, Lesage S, Earley C . The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions ("mimics"). Sleep Med. 2009; 10(9):976-81. PMC: 2769267. DOI: 10.1016/j.sleep.2008.09.015. View